Frangakis Constantine E, Rubin Donald B
Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Biometrics. 2002 Mar;58(1):21-9. doi: 10.1111/j.0006-341x.2002.00021.x.
Many scientific problems require that treatment comparisons be adjusted for posttreatment variables, but the estimands underlying standard methods are not causal effects. To address this deficiency, we propose a general framework for comparing treatments adjusting for posttreatment variables that yields principal effects based on principal stratification. Principal stratification with respect to a posttreatment variable is a cross-classification of subjects defined by the joint potential values of that posttreatment variable tinder each of the treatments being compared. Principal effects are causal effects within a principal stratum. The key property of principal strata is that they are not affected by treatment assignment and therefore can be used just as any pretreatment covariate. such as age category. As a result, the central property of our principal effects is that they are always causal effects and do not suffer from the complications of standard posttreatment-adjusted estimands. We discuss briefly that such principal causal effects are the link between three recent applications with adjustment for posttreatment variables: (i) treatment noncompliance, (ii) missing outcomes (dropout) following treatment noncompliance. and (iii) censoring by death. We then attack the problem of surrogate or biomarker endpoints, where we show, using principal causal effects, that all current definitions of surrogacy, even when perfectly true, do not generally have the desired interpretation as causal effects of treatment on outcome. We go on to forrmulate estimands based on principal stratification and principal causal effects and show their superiority.
许多科学问题要求对治疗比较进行调整,以考虑治疗后的变量,但标准方法所依据的估计量并非因果效应。为解决这一缺陷,我们提出了一个通用框架,用于比较治疗,并对治疗后的变量进行调整,该框架基于主分层产生主效应。关于治疗后变量的主分层是根据正在比较的每种治疗下该治疗后变量的联合潜在值定义的受试者交叉分类。主效应是主层内的因果效应。主层的关键特性是它们不受治疗分配的影响,因此可以像任何治疗前协变量一样使用,例如年龄类别。因此,我们的主效应的核心特性是它们始终是因果效应,并且不会受到标准的治疗后调整估计量的复杂性的影响。我们简要讨论了这种主因果效应是最近三个对治疗后变量进行调整的应用之间的联系:(i)治疗不依从性,(ii)治疗不依从后缺失结局(退出),以及(iii)因死亡进行的删失。然后我们探讨替代或生物标志物终点的问题,在这个问题中,我们使用主因果效应表明,即使所有当前的替代定义完全正确,它们通常也没有作为治疗对结局的因果效应的理想解释。我们接着基于主分层和主因果效应制定估计量,并展示它们的优越性。